ROYCE & ASSOCIATES LP - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 66 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$296,000
-20.2%
50,0000.0%0.00%
-25.0%
Q2 2023$371,000
-21.5%
50,0000.0%0.00%
-20.0%
Q1 2023$472,50050,0000.01%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sentinus, LLC 149,050$1,408,5230.47%
Intrepid Financial Planning Group LLC 19,000$179,5500.09%
PERRITT CAPITAL MANAGEMENT INC 12,000$113,4000.06%
Interchange Capital Partners, LLC 11,413$107,8530.06%
Virtu Financial LLC 21,650$2050.02%
CREATIVE FINANCIAL DESIGNS INC /ADV 15,000$141,7500.02%
J. Goldman & Co LP 42,228$399,0550.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 63,966$604,4790.02%
KENNEDY CAPITAL MANAGEMENT LLC 46,311$437,6390.01%
683 Capital Management, LLC 16,000$151,2000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders